| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| 5-year Follow up Study on the Comparative Performance of Two-piece Zirconia and Titanium Implant | ohne Phasenangabe | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | Phase II | rekrutiert |
| A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agit | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of | Phase III | rekrutiert |
| A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanc | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal | ohne Phasenangabe | rekrutiert |
| A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antib | Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients W | Phase I | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase II | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase III | rekrutiert |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refra | Phase I | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembroliz | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pem | Phase III | rekrutiert |
| A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate | Phase II | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Int | Phase II / Phase III | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism | Phase III | rekrutiert |
| A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney | Phase II | rekrutiert |
| A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to | Phase III | rekrutiert |
| A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PA | Phase II | rekrutiert |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spas | Phase I / Phase II | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participan | Phase I / Phase II | rekrutiert |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept | Phase III | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzhei | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has | Phase II / Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Ed | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in P | Phase I / Phase II | rekrutiert |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part | Phase III | rekrutiert |
| A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis De | Phase III | rekrutiert |
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD | Phase II | rekrutiert |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atr | Phase II | rekrutiert |
| A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients W | Phase I / Phase II | rekrutiert |
| AI Screening for Diabetic Retinopathy | — | rekrutiert |
| AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI | — | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | — | rekrutiert |
| Ablation of Consecutive Atrial Tachycardia | ohne Phasenangabe | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Trea | Phase III | rekrutiert |
| An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy | Phase II | rekrutiert |
| An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR1 | Phase I / Phase II | rekrutiert |
| An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Pa | Phase II | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hyp | ohne Phasenangabe | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of | ohne Phasenangabe | rekrutiert |
| BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System | ohne Phasenangabe | rekrutiert |
| Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreat | Phase II | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Biological Determinants and Neural Compensation of Dysphagia in Parkinson's Disease | — | rekrutiert |
| Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) | — | rekrutiert |
| CRS Questionnaire Validation Project | — | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Chronic Outcome Monitoring for DBS in Dystonia | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phas | — | rekrutiert |
| Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis | — | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Pl | Phase II | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia | Phase II | rekrutiert |
| Deep Brain Stimulation (DBS) Retrospective Outcomes Study | — | rekrutiert |
| Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap) | — | rekrutiert |
| Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostat | Phase III | rekrutiert |
| Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Ca | — | rekrutiert |
| Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells | — | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Phase II | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpe | Phase II | rekrutiert |
| EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Condition | ohne Phasenangabe | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS) | ohne Phasenangabe | rekrutiert |
| Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged | Phase III | rekrutiert |
| Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. | Phase III | rekrutiert |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participant | Phase III | rekrutiert |
| Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to E | Phase III | rekrutiert |
| Electrophysiological Registry Duesseldorf | — | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Enhancing Palliative Care in ICU | ohne Phasenangabe | rekrutiert |
| Estimation of Outcome and Quality of Life in ECMO Patients | — | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluation Of Outcomes Following Rotator Cuff Repair Using the REGENETEN Bioinductive Implant | — | rekrutiert |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia | Phase III | rekrutiert |
| Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-De | Phase III | rekrutiert |
| Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORP | ohne Phasenangabe | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| Follitropin Delta in Long GnRH-agonist Protocol | — | rekrutiert |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | — | rekrutiert |
| Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the | — | rekrutiert |
| Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor | Phase II | rekrutiert |
| GEL & MEDication Dysphagia | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 | Phase II | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German-funded Laparoscopic Approach to Cervical Cancer | ohne Phasenangabe | rekrutiert |
| Global Registry and Natural History Study for Mitochondrial Disorders | — | rekrutiert |
| Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Tra | ohne Phasenangabe | rekrutiert |
| Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW) | — | rekrutiert |
| High Dose Steroids in Children With Stroke | Phase III | rekrutiert |
| Home-based Gait and Balance Training in Patients With Movement Disorders | ohne Phasenangabe | rekrutiert |
| Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project | — | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, A | — | rekrutiert |
| Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer | — | rekrutiert |
| Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Intermittent Fasting to Improve Insulin Secretion | ohne Phasenangabe | rekrutiert |
| International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-regist | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| International Wilson's Disease Patient Registry (iWilson Registry) | — | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating | Phase III | rekrutiert |
| Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With | Phase I / Phase II | rekrutiert |
| LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus | ohne Phasenangabe | rekrutiert |
| Liquid Biopsy in Paraneoplastic Neurological Syndromes | — | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator | — | rekrutiert |
| Lumbar Drainage of Intraventricular Hemorrhage | ohne Phasenangabe | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| METABolic Deterioration in HTX Determines Outcomes | — | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach | — | rekrutiert |
| Mechanisms Of Disease Progression in Aortic Stenosis - the MODAS Study | — | rekrutiert |
| Medtronic Cardiac Surgery PMCF Registry | — | rekrutiert |
| Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivit | — | rekrutiert |
| Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personalit | ohne Phasenangabe | rekrutiert |
| Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STE | — | rekrutiert |
| Mitochondrial Substrate Utilization in the Diabetic Human Heart | — | rekrutiert |
| MitraClip® Registry | — | rekrutiert |
| Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation | — | rekrutiert |
| Multicenter Glaucoma Study Investigating Standalone Canaloplasty | ohne Phasenangabe | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections | Phase III | rekrutiert |
| NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| NeoRad Breast Cancer Study | Phase III | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| One-Month DAPT in CABG Patients | Phase III | rekrutiert |
| Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Cathete | ohne Phasenangabe | rekrutiert |
| Overfeeding Induced Fat-tissue Stimulation | ohne Phasenangabe | rekrutiert |
| PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group | — | rekrutiert |
| PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND | Phase II | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced B | Phase III | rekrutiert |
| Patient Retrospective Outcomes (PRO) | — | rekrutiert |
| Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally | Phase II | rekrutiert |
| Percutaneous Transluminal Angioplasty Registry | — | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Phase II / Phase III | rekrutiert |
| Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negativ | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanc | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Phenotyping Heterogeneity and Regionality of the Aorta | — | rekrutiert |
| Post COVID-19 Condition | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [Cross | ohne Phasenangabe | rekrutiert |
| Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. | Phase II | rekrutiert |
| Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed C | — | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Ad | ohne Phasenangabe | rekrutiert |
| Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients | — | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectivenes | — | rekrutiert |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | ohne Phasenangabe | rekrutiert |
| REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Fa | — | rekrutiert |
| REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs | ohne Phasenangabe | rekrutiert |
| Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for C | — | rekrutiert |
| Randomization of Single vs Multiple Arterial Grafts | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real-Life Chronic Rhinosinusitis Outcome Registry | — | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | — | rekrutiert |
| Registry of Device Implantation | — | rekrutiert |
| Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer | ohne Phasenangabe | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of | Phase IV | rekrutiert |
| STIMPulseControl Ancillary Speech Study | ohne Phasenangabe | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR | Phase III | rekrutiert |
| Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer | Phase II | rekrutiert |
| Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor | Phase III | rekrutiert |
| Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Second | Phase III | rekrutiert |
| Smart Monitoring Assessing Spasticity-related Health | — | rekrutiert |
| Strategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation i | — | rekrutiert |